Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;42(Suppl 1):1-2.
doi: 10.1007/s40261-022-01148-4. Epub 2022 May 9.

Foreword

Beatriz Mínguez  1   2   3   4 , José Luis Lledó-Navarro  5
Affiliations

Foreword

Beatriz Mínguez et al. Clin Drug Investig. 2022 Jun.

Erratum in

  • Correction to: Foreword.
    Mínguez B, Lledó-Navarro JL. Mínguez B, et al. Clin Drug Investig. 2022 Jun;42(Suppl 1):3. doi: 10.1007/s40261-022-01167-1. Clin Drug Investig. 2022. PMID: 35616885 Free PMC article. No abstract available.
  • Correction to: Foreword.
    Mínguez B, Lledó-Navarro JL. Mínguez B, et al. Clin Drug Investig. 2022 Aug;42(8):703. doi: 10.1007/s40261-022-01174-2. Clin Drug Investig. 2022. PMID: 35788977 Free PMC article. No abstract available.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there were no conflicts of interest.

References

    1. Gines P, Krag A, Abraldes JG, Solá E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398:1359–1376. doi: 10.1016/S0140-6736(21)01374-X. - DOI - PubMed
    1. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151–171. doi: 10.1016/j.jhep.2018.09.014. - DOI - PubMed
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:293–313. doi: 10.1038/s41575-020-00395-0. - DOI - PubMed
    1. Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15:599–616. doi: 10.1038/s41571-018-0073-4. - DOI - PMC - PubMed

LinkOut - more resources